Skip to main content
Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: The influence of dapagliflozin on cardiac remodeling, myocardial function and metabolomics in type 1 diabetes mellitus rats

Fig. 1

Glycemia evaluated before diabetes mellitus (DM) induction (a); 7 days after DM induction (b); and at the end of the experiment (c). Data are expressed as individual values and means ± standard deviation or medians and percentiles. C: control (n = 14); DM: diabetes mellitus (n = 15); DM + DAPA: DM treated with dapagliflozin (n = 13); ANOVA and Tukey or Kruskal-Wallis and Dunn; * p < 0.001 vs. C; # p < 0.001 vs. DM.

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us